licensing agreement
ERS Genomics Licenses CRISPR IP to GenOway
ERS Genomics was founded to provide access to CRISPR-Cas9 intellectual property shared by Emmanuelle Charpentier, Jennifer Doudna, and others.
Crown Bioscience Licenses Cell Line Portfolio From NCI, ATCC
The ATCC deal gives CrownBio access to more than 140 cell lines now and 4,000 cell lines in the future, and the NCI deal gives the firm access to 100 cell lines.
Guardant Health to License IP to Foundation Medicine for $25M, Royalties Under Settlement Agreement
The parties have agreed to settle patent infringement lawsuits filed by Guardant against Foundation Medicine, now a Roche subsidiary.
Dutch Seed Firm Bejo Takes License to Corteva Agriscience, Broad Institute CRISPR IP
Corteva and Broad have been nonexclusively licensing their respective CRISRP-Cas9 intellectual property for agricultural applications since 2017.
ERS Genomics Licenses CRISPR Patents to GenScript Biotech
GenScript said it will use the license to improve its own synthetic sgRNA, gRNA plasmid, gRNA library, and cell line engineering services.
Apr 19, 2021
ERS Genomics Licenses CRISPR Patents to Nuvisan
Mar 10, 2021
ERS Genomics Licenses CRISPR Patents to Setsuro Tech
Feb 4, 2021
Dec 28, 2020